Trial Profile
Rho-kinase in patients with atherosclerosis: Effects of statins [HMG-CoA reductase inhibitors] a randomized clinical trial comparing ezetimibe/simvastatin and simvastatin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary) ; Ezetimibe; Ezetimibe/simvastatin
- Indications Atherosclerosis; Dyslipidaemias; Lipid metabolism disorders
- Focus Pharmacodynamics
- 26 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 29 Nov 2007 New trial record.